3-186570924-T-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_016306.6(DNAJB11):c.27T>A(p.Phe9Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000206 in 1,603,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016306.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB11 | NM_016306.6 | c.27T>A | p.Phe9Leu | missense_variant | 1/10 | ENST00000265028.8 | NP_057390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB11 | ENST00000265028.8 | c.27T>A | p.Phe9Leu | missense_variant | 1/10 | 1 | NM_016306.6 | ENSP00000265028.3 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152010Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000213 AC: 5AN: 235284Hom.: 0 AF XY: 0.0000235 AC XY: 3AN XY: 127390
GnomAD4 exome AF: 0.0000186 AC: 27AN: 1451622Hom.: 0 Cov.: 32 AF XY: 0.0000180 AC XY: 13AN XY: 721616
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152128Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74372
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 22, 2021 | This sequence change replaces phenylalanine with leucine at codon 9 of the DNAJB11 protein (p.Phe9Leu). The phenylalanine residue is weakly conserved and there is a small physicochemical difference between phenylalanine and leucine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with DNAJB11-related conditions. This variant is present in population databases (rs538824536, ExAC 0.03%). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at